Next, we increased ACSL4 expression in the context of MARK4 knockdown and detected the expression of these lipid oxidation proteins to confirm that MARK4 deficiency promotes lipid metabolism in the DCM model by downregulating ACSL4 expression (Fig. 8A). This evidence concerns the gene MARK4 and familial dilated cardiomyopathy.